Home  >  Products  >  COX6B1 (cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) ) Blocking Peptide (the N terminal of COX6B1)(100ug)
COX6B1 (cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) ) Blocking Peptide (the N terminal of COX6B1)(100ug)

COX6B1 (cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) ) Blocking Peptide (the N terminal of COX6B1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-COX6B1 Antibody (ARP66777_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP66777
Size: 100ug
Weight: 10kDa
Gene: 1340
Format: Lyophilized powder
Target: Cytochrome c oxidase (COX), the terminal enzyme of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. It is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may be involved in the regulation and assembly of the complex. This nuclear gene encodes subunit VIb. Mutations in this gene are associated with severe infantile encephalomyopathy. Three pseudogenes COX6BP-1, COX6BP-2 and COX6BP-3 have been found on chromosomes 7, 17 and 22q13.1-13.2, respectively.
Alternative names: COX6B; COXG; COXVIb1
See Full Product Listings >